Neurocognitive late effects of pediatric brain tumors of the posterior fossa: A quantitative review

Journal of the International Neuropsychological Society

Volumn 19, Issue 1, 2013, Pages 44-53

  Robinson, Kristen E ^a   Fraley, Claire E ^a   Pearson, Matthew M ^b   Kuttesch, John F ^c   Compas, Bruce E ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c PENN STATE CHILDREN S HOSPITAL   (United States)

Author keywords

Brain tumor; Children; Cognitive; Infratentorial; Meta analysis; Sequelae

Indexed keywords

EID: 84872067073     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617712000987     Document Type: Review

References (64)

1. Aarsen, F.K., Van Dongen, H.R., Paquier, P.F., Van Mourik, M., & Catsman-Berrevoets, C.E. (2004). Long-term sequelae in children after cerebellar astrocytoma surgery. Neurology, 62, 1311-1316. doi:10.1212/01.WNL.0000120549. 77188.38
2. Alexander, E., & Loeffler, J.S. (1999). The case for radiosurgery. Clinical Neurosurgery, 45, 32-40.
3. Ater, J.L., Moore, B.D., Francis, D.J., Castillo, R., Slopis, J., & Copeland, D.R. (1996). Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: Utilization of a neurological severity score. Journal of Child Neurology, 11, 462-469.
4. Beebe, D.W., Ris, M.D., Armstrong, F.D., Fontanesi, J., Mulhern, R.K., Holmes, E., & Wisoff, J.H. (2005). Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). Journal of Clinical Oncology, 23, 5198-5204. doi:10.1200/JCO.2005.06.117
5. Benesch, M., Spiegl, K., Winter, A., Passini, A., Lackner, H., Moser, A., y Urban, C. (2009). A scoring system to quantify late effects in children after treatment for medulloblastoma/ependy-moma and its correlation with quality of life and neurocognitive functioning. Child's Nervous System, 25, 173-181. doi:10.1007/s00381-008-0742-1
6. Bonner, M.J., Hardy, K.K., Willard, V.W., Anthony, K.K., Hood, M., & Gururangan, S. (2008). Social functioning and facial expression recognition in survivors of pediatric brain tumors. Journal of Pediatric Psychology, 33, 1142-1152. doi:10.1093/jpepsy/jsn035
7. Borenstein, M., & Rothstein, H. (2005). Comprehensive meta-analysis computer program and manual. Englewood Cliffs, NJ: Biostat, Inc.
8. Callu, D., Viguier, D., Laroussinie, F., Puget, S., Boddaert, N., Kieffer, V., y Dellatolas, G. (2009). Cognitive and academic outcome alter benign or malignant cerebellar tumor in children. Cognitive and Behavioral Neurology, 22, 270-278. doi:10.1097/WNN.0b013e3181bf2d4c
9. Central Brain Tumor Registry of the United States (2008). Statistical report: Primary brain tumors in the United States, 2000-2004. Hinsdale, IL: the Central Brain Tumor Registry of the United States.
10. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
11. Copeland, D.R., deMoor, C., Moore, B.D., & Ater, J.L. (1999). Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study. Journal of Clinical Oncology, 17, 3476-3486. doi:0732-183X/99/1711-3476
12. Dennis, M., Spiegler, B.J., Hetherington, C.R., & Greenberg, M.L. (1996). Neuropsychological sequelae of the treatment of children with medulloblastoma. Journal of Neurooncology, 29, 91-101. doi:10.1007/BF00165522
13. Docking, K.M., Ward, E.C., & Murdoch, B.E. (2005). Language outcomes subsequent to treatment of brainstem tumour in childhood. Neurorehabilitation, 20, 107-124. doi:1053-8135/05
14. Duffner, P.K., Cohen, M.E., & Thomas, P. (1983). Late effects of treatment on the intelligence of children with posterior fossa tumors. Cancer, 51, 233-237. doi:0008-543X/83/0115/0233
15. El-Ghandour, N.M. (2011). Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in the treatment of obstructive hydrocephalus due to posterior fossa tumors in children. Child's Nervous System, 27, 117-126.
16. Fuemmeler, B.F., Elkin, T.D., & Mullins, L.L. (2002). Survivors of childhood brain tumors: Behavioral, emotional, and social adjustment. Clinical Psychology Review, 22, 547-585.
17. George, A.P., Kuehn, S.M., Vassilyadi, M., Richards, P.M.P., Parlow, S.E., Keene, D.L., & Ventureyra, E.C.G. (2003). Cognitive sequelae in children with posterior fossa tumors. Pediatric Neurology, 28, 42-47. doi:10.1016/S0887-8994(02)00471-X
18. Goldwein, J.W., Radcliffe, J., Johnson, J., Moshang, T., Packer, R.J., Sutton, L.N., y D'Angio, G.J. (1996). Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). International Journal of Radiation Oncology, Biology, Physics, 14, 899-904.
19. Grill, J., Renaux, V.K., Bulteau, C., Viguier, D., Levy-Piebois, C., Sainte-Rose, C., y Kalifa, C. (1999). Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. International Journal of Radiation Oncology Biology and Physics, 45, 137-145. doi:S0360-3016/99/00177-7
20. Gurney, J.G., Kadan-Lottick, N.S., Packer, R.J., Neglia, J.P., Sklar, C.A., Punyko, J.A., y Robison, L.L. (2003). Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors. Cancer, 97, 663-673. doi:10.1002/cncr.11095
21. Hardy, K.K., Bonner, M.J., Willard, V.W., Watral, M.A., & Gururangan, S. (2008). Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma. Psychooncology, 17, 1157-1161. doi:10.1002/pon.1349
22. Hetherington, R., Dennis, M., & Spiegler, B. (2000). Perception and estimation of time in long-term survivors of childhood posterior fossa tumors. Journal of the International Neuropsychological Society, 6, 682-692.
23. Holmquist, L.A., & Scott, J. (2002). Treatment, age, and time-related predictors of behavioral outcome in pediatric brain tumor survivors. Journal of Clinical Psychology in Medical Settings, 9, 315-321. doi:10.1023/A: 1020791018897
24. Howlader, N., Noone, A.M., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., y Edwards, B.K. (Eds.). (2011). SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute.
25. Jain, N., Krull, K.R., Brouwers, P., Chintagumpala, M.M., & Woo, S.Y. (2008). Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma. Pediatric Blood and Cancer, 51, 275-279. doi:10.1002/pbc.21590
26. Kao, G.D., Goldwein, J.W., Schultz, D.J., Radcliffe, J., Sutton, L., & Lange, B. (1994). The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors. Cancer, 74, 965-971.
27. Karatekin, C., Lazareff, J.A., & Asarnow, R.F. (2000). Relevance of the cerebellar hemispheres for executive functions. Pediatric Neurology, 22, 106-112. doi:10.1016/S0887-8994(99)00128-9
28. Kieffer-Renauz, V., Bulteau, C., Grill, J., Kalifa, C., Viguier, D., & Jambaque, I. (2000). Patterns of neuropsychological deficits in children with medulloblastoma according to craniospinal irradiation doses. Developmental Medicine and Child Neurology, 42, 741-745. doi:10.1111/j.1469-8749.2000.tb00036. x
29. King, T.Z., Fennell, E.B., Williams, L., Algina, J., Boggs, S., Crosson, B., & Leonard, C. (2004). Verbal memory abilities in children with brain tumors. Child Neuropsychology, 10, 76-88. doi:10.1080/09297040490911096
30. Levisohn, L., Cronin-Golomb, A., & Schmahmann, J.D. (2000). Neuropsychological consequences of cerebellar tumour resection in children: Cerebellar cognitive affective syndrome in a paediatric population. Brain, 123, 1041-1050. doi:10.1093/brain/123.5.1041
31. Lipsey, M.W., & Wilson, D.B. (2000). Practical meta-analysis. Thousand Oaks: SAGE Publications.
32. Mabbott, D.J., Penkman, L., Witol, A., Strother, D., & Bouffet, E. (2008). Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology, 22, 159-168. doi:10.1037/0894-4105.22.2.159
33. Maddrey, A.M., Bergeron, J.A., Lombardo, E.R., McDonald, N.K., Mulne, A.F., Barenberg, P.D., & Bowers, D.C. (2005). Neuro-psychological performance and quality of life of 10 year survivors of childhood medulloblastoma. Journal of Neurooncology, 72, 245-253. doi:10.1007/s11060-004- 3009-z
34. Merchant, T.E., Pollack, I.F., & Loeffler, J.S. (2010). Brain tumors across the age spectrum: Biology, therapy and late effects. Seminars in Radiation Oncology, 20, 58-66. doi:10.1016/j.semradonc.2009.09.005
35. Moore, B.D., Ater, J.L., & Copeland, D.R. (1992). Improved neuropsychological outcome in children with brain tumors diagnosed during infancy and treated without cranial irradiation. Journal of Child Neurology, 7, 281-290. doi:10.1177/088307389200700308
36. Mulhern, R.K., & Butler, R.W. (2004). Neurocognitive sequelae of childhood cancers and their treatment. Pediatric Rehabilitation, 7, 1-14. doi:10.1080/13638490310001655528
37. Mulhern, R.K., Hancock, J., Fairclough, D., & Kun, L. (1992). Neuropsychological status of children treated for brain tumors: A critical review and integrative analysis. Medical and Pediatric Oncology, 20, 181-191. doi:10.1002/mpo.2950200302
38. Mulhern, R.K., Kepner, J.L., Thomas, P.R., Armstrong, F.D., Friedman, H.S., & Kun, L.E. (1998). Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. Journal of Clinical Oncology, 16, 1723-1728. doi:0732-183X/98/1605-0041
39. Mulhern, R.K., & Kun, L.E. (1985). Neuropsychologic function in children with brain tumors III: Interval changes in the six months following treatment. Medical and Pediatric Oncology, 13, 318-324. doi:10.1002/mpo. 2950130604
40. Mulhern, R.K., Palmer, S.L., Reddick, W.E., Glass, J.O., Kun, L.E., Taylor, J., y Gajjar, A. (2001). Risk of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. Journal of Clinical Oncology, 19, 472-479. doi:0732-183X/01/1902-472
41. Mulhern, R.K., Reddick, W.E., Palmer, S.L., Glass, J.O., Elkin, T.D., Kun, L.E., y Gajjar, A. (1999). Neurocognitive deficits in medulloblastoma survivors and white matter loss. Annals of Neurology, 46, 834-841. doi:10.1002/1531-8249(199912)46:6, 834::AID-ANA5.3.0.CO;2-M
42. Nagel, B.J., Delis, D.C., Palmer, S.L., Reeves, C., Gajjar, A., & Mulhern, R.K. (2006). Early patterns of verbal memory impairment in children treated for medulloblastoma. Neuropsychology, 20, 105-122. doi:10.1037/0894-41. 0.20.1.105
43. Nathan, P.C., Patel, S.K., Dilley, K., Goldsby, R., Harvey, J., Jacobsen, C., y Armstrong, D. (2007). Guidelines for identification of, advocacy for, and interventions in neurocognitive problems in survivors of childhood cancer: A report from the Children's Oncology Group. Archives of Pediatric and Adolescent Medicine, 161, 798-806.
44. Ness, K.K., & Gurney, J.G. (2007). Adverse late effects of childhood cancer and its treatment on health and performance. Annual Review of Public Health, 28, 279-302. doi:10.1146/annurev.publhealth.28.021406.144049
45. Palmer, S.L., Goloubeva, O., Reddick, W.E., Glass, J.O., Gajjar, A., Kun, L., y Mulhern, R.K. (2001). Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. Journal of Clinical Oncology, 19, 2302-2308. doi:0732-183X/01/1908-2302
46. Palmer, S.L., Hassall, T., Evankovich, K., Mabbott, D.J., Bonner, M., Deluca, C., y Gajjar, A. (2010). Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neurooncology, 12, 1311-1317. doi:10.1093/neuonc/noq094
47. Papazoglou, A., King, T.Z., Morris, R.D., & Krawiecki, N.S. (2008). Cognitive predictors of adaptive functioning vary according to pediatric brain tumor location. Developmental Neuropsychology, 33, 505-520. doi:10.1080/ 87565640802101490
48. Patel, S.K., Mullins, W.A., O'Neil, S.H., & Wilson, K. (2011). Neuropsychological differences between survivors of supra-tentorial and infratentorial brain tumours. Journal of Intellectual Disabilities Research, 55, 30-40. doi:10.1111/j.1365-2788. 2010.01344.x
49. Prentice, D.A., & Miller, D.T. (1992). When small effects are impressive. Psychological Bulletin, 112, 160-164. doi:10.1037/0033-2909.112.1. 160
50. Radcliffe, J., Bunin, G.R., Sutton, L.N., Goldwein, J.W., & Phillips, P.C. (1994). Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: Age-dependent effects of whole brain radiation. International Journal of Developmental Neuroscience, 12, 327-334. doi:0736-5748/94
51. Reeves, C.B., Palmer, S.L., Reddick, W.E., Merchant, T.E., Buchanan, G.M., Gajjar, A., & Mulhern, R.K. (2006). Attention and memory functioning among pediatric patients with medulo-blastoma. Journal of Pediatric Psychology, 31, 272-280. doi:10.1093/jpepsy/jsj019
52. Reimers, T.S., Ehrenfels, S., Mortensen, E.L., Schmiegelow, M., Sonderkaer, S., Carstensen, H., y Muller, J. (2003). Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Medical and Pediatric Oncology, 40, 26-34. doi:10.1002/mpo.10211
53. Riva, D., & Giorgi, C. (2000). The cerebellum contributes to higher functions during development: Evidence from a series of children surgically treated for posterior fossa tumours. Brain, 123, 1051-1061. doi:10.1093/brain/ 123.5.1051
54. Riva, D., Giorgi, C., Nichelli, F., Bulgheroni, S., Massimino, M., Cefalo, G., y Pantaleoni, C. (2002). Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology, 59, 48-53.
55. Robinson, K.E., Kuttesch, J.F., Champion, J.E., Andreotti, C.F., Hipp, D.W., Bettis, A., y Compas, B.E. (2010). A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors. Pediatric Blood and Cancer, 55, 525-531. doi:10.1002/pbc.22568
56. Ronning, C., Sundet, K., Due-Tonnessen, B., Lundar, T., & Helseth, E. (2005). Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood. Pediatric Neurosurgery, 41, 5-21. doi:10.1159/000084860
57. Rosenthal, R. (1991). Meta-analysis procedures for social research: Applied social research methods series, Vol. 6. Beverly Hills: Sage Publication.
58. Scott, R.B., Stoodley, C.J., Anslow, P., Paul, C., Stein, J.F., Sugden, E.M., & Mitchell, C.D. (2001). Lateralized cognitive deficits in children following cerebellar lesions. Developmental Medicine and Child Neurology, 43, 685-691. doi:10.1017/S0012162201001232
59. Shadish, W.R., & Haddock, C.K. (1994). Combining estimates of effect size. In H. Cooper & L.V. Hedges, (Eds.), The handbook of research synthesis (pp. 261-281). New York, NY: Russell Sage Foundation.
60. Silber, J.H., Radcliffe, J., Peckham, V., Perilongo, G., Kishnani, P., Fridman, M., y Meadows, A.T. (1992). Whole-brain irradiation and decline in intelligence: The influence of dose and age on IQ score. Journal of Clinical Oncology, 10, 1390-1396. doi:0732-183X/92/1009-0005
61. Stargatt, R., Rosenfeld, J.V., Maixner, W., & Ashley, D. (2007). Multiple factors contribute to neuropsychological outcome in children with posterior fossa tumors. Developmental Neuropsy-chology, 32, 720-748. doi:10.1080/87565640701376151
62. Steinlin, M., Imfeld, S., Zulauf, P., Boltshauser, E., Lovblad, K., Luthy, A.R., y Kaufmann, F. (2003). Neuropsychological longterm sequelae after posterior fossa tumour resection during childhood. Brain, 126, 1998-2008. doi:10.1093/brain/awg195
63. Yang, T., Wong, T., Cheng, L., Chang, T., Hsu, T., Chen, S., & Chuang, T. (1997). Neuropsychological sequelae after treatment for medulloblastoma in childhood: The Taiwan experience. Child's Nervous System, 13, 77-80. doi:10.1007/s003810050046
64. Zebrack, B.J., Gurney, J.G., Oeffinger, K., Whitton, J., Packer, R.J., Mertens, A., y Zeltzer, L.K. (2004). Psychological outcomes in long-term survivors of childhood brain cancer: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 22, 999-1006.